TP53 and breast carcinoma: Interestingly, induction of apoptosis in breast cancer cells leads to CISD2 interaction with the inhibitor of apoptosis-stimulating protein of p53 (iASPP) and a structural model of holo-CISD2 in interaction with iASPP has been proposed [31].